Skip to content
Vertex Vault

The Zimbabwean Government Rejects ‘One-Sided’ US Health Aid Package Due to Information Concerns

Medical aid image
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a major US healthcare agreement valued at $367m (£272m) over five years due to the United States' request for sensitive biological samples.

This rejection came to light after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "lopsided".

A government spokesman has since explained that the United States was requesting health data for research and commercial purposes while was not willing to share the benefits from any future vaccines.

"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged more dialogue to secure a deal suitable to both sides so the nation's vital HIV programme can be sustained.

Wider Background

This rejection comes after a comparable situation in Kenya, where a court halted a similar health funding agreement following concerns were raised about the safety of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.

According to reports, Sixteen African countries have so far signed similar health pacts, constituting more than $18.3bn in new funding.

Specifics of the Declined Agreement

This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported initiatives," Tremont said.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to share its biological resources and data for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.

"In essence, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our population should a new pandemic emerge."

National Interest and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously set up through the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This system is designed to guarantee that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."

The government's concerns over the US deal "are not meant as anti-American sentiment," he added.

"We welcome continued dialogue with our American counterparts on how subsequent collaboration might be designed in a manner that honours the sovereignty and interests of both nations."

Medical Community Reaction

Medical experts stated it understood the government's concerns, but recommended that negotiations must proceed given that a large portion of the country's HIV programmes relied on external financing.

"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group commented.

The halted deal highlights the complex debate between accepting vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.

The writer

Jessica Mason

A tech enthusiast and software developer with over a decade of experience in AI and digital transformation, passionate about sharing knowledge.

Vertex Vault

Type to search articles.